Skip to Content
Merck
  • A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion protein.

A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion protein.

mBio (2023-12-20)
Marlies Ballegeer, Revina C van Scherpenzeel, Teresa Delgado, Maria Iglesias-Caballero, Blanca García Barreno, Shubham Pandey, Scott A Rush, Joost A Kolkman, Vicente Mas, Jason S McLellan, Xavier Saelens
ABSTRACT

Human metapneumovirus (hMPV) is an important respiratory pathogen for which no licensed antivirals or vaccines exist. Single-domain antibodies represent promising antiviral biologics that can be easily produced and formatted. We describe the isolation and detailed characterization of two hMPV-neutralizing single-domain antibodies that are directed against the fusion protein F. One of these single-domain antibodies broadly neutralizes hMPV A and B strains, can prevent proteolytic maturation of F, and binds to an epitope in the F trimer interface. This suggests that hMPV pre-F undergoes trimer opening or "breathing" on infectious virions, exposing a vulnerable site for neutralizing antibodies. Finally, we show that this single-domain antibody, fused to a human IgG1 Fc, can protect cotton rats against hMPV replication, an important finding for potential future clinical applications.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Human Metapneumovirus 75.1 Antibody, clone 1B7, clone 1B7, Chemicon®, from mouse